February 27, 2017 / 6:31 AM / 6 months ago

BRIEF-Xbrane Biopharma reports positive in-vitro biosimilarity data on Xlucane

Feb 27 (Reuters) - Xbrane Biopharma AB:

* Reports positive in-vitro biosimilarity data on Xlucane

* Study demonstrates no significant difference of Xlucane versus reference product on most important parameters Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below